Ship Healthcare (3360) Q3 2025 earnings summary

Executive summary

• Net sales for the nine months ended December 31, 2024, rose 8.7% year-over-year to ¥492,272 million, with profit attributable to owners of parent up 45.6% to ¥10,517 million.

• Operating profit was ¥15,121 million, nearly flat year-over-year, while ordinary profit increased 4.8% to ¥16,545 million.

• Performance was in line with plan, supported by strong project execution in the Total Pack Produce business and ongoing medium-term management strategies.

Financial highlights

• Gross profit increased to ¥46,185 million from ¥45,571 million year-over-year.

• Net income per share rose to ¥111.48 from ¥76.57 year-over-year.

• Comprehensive income grew 21.8% year-over-year to ¥10,743 million.

• Total assets decreased to ¥378,433 million from ¥387,562 million at the previous fiscal year-end.

• Equity capital ratio improved to 38.4% from 36.0% at the previous fiscal year-end.

Outlook and guidance

• Full-year net sales forecast is ¥640,000 million (up 1.4% year-over-year), with operating and ordinary profit both projected at ¥26,000 million.

• Profit attributable to owners of parent is forecast at ¥15,000 million (up 8.7% year-over-year), with net income per share of ¥158.98.

• No changes to previously announced financial forecasts.